Frontlight ResearchEarly access
Trial site
Uniwersytecki Szpital Kliniczny Im. Wojskowej Akademii Medycznej Uniwersytetu Medycznego W Lodzi Centralny Szpital Weteranow SPZOZ
- 3running trials
- 5closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Heart failure3 trials
- COPD2 trials
- Chronic kidney disease1 trial
- Idiopathic pulmonary fibrosis1 trial
- Multiple sclerosis1 trial
- Phase
- Phase 37 trials
- Phase 21 trial
- Status
- Completed5 trials
- Active, not recruiting2 trials
- Recruiting1 trial
- Lead sponsor
- Chiesi Farmaceutici S.p.A.2 trials
- Bristol-Myers Squibb Services Unlimited Company1 trial
- Eli Lilly and Company1 trial
- John Paul II Hospital, Krakow1 trial
- Medical University Of Warsaw1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Empagliflozin and dapagliflozin for improvement of outcome in patients with acute heart failure
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure1 recruiting
Closed trials
Terminated
Completed
Completed
The efficacy and safety of two doses of CHF6001 DPI as add-on to maintenance COPD triple therapy
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026